Clinical Considerations in Management of Hypertrophic Cardiomyopathy in Pregnancy
JACC · 2026
DOI: 10.1016/j.jacc.2026.06.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC, 2026. Verfasst von Omar M Abdelfattah und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Dell Medical School, University of Texas at Austin, Austin, Texas, USA; Ascension Texas Cardiovascular, Ascensio…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Pregnancy Complications, Cardiovascular, Disease Management. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) in pregnancy presents unique hemodynamic and arrhythmic challenges despite generally low maternal mortality. This JACC State-of-the-Art Review synthesizes current evidence on preconception risk stratification, genetic counseling, antepartum surveillance, arrhythmia management, and delivery and postpartum care. Key considerations include assessing left ventricular outflow tract obstruction, systolic function, and arrhythmia burden and applying CARPREG II (Cardiac Disease in Pregnancy Study II)/modified World Health Organization classifications to guide monitoring intensity. Pregnancy is typically well tolerated in low-risk women, whereas severe obstruction or systolic dysfunction confers high maternal-fetal risk. Multidisciplinary pregnancy heart team management remains essential to optimize outcomes and support informed decision making across the reproductive continuum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Dell Medical School, University of Texas at Austin, Austin, Texas, USA; Ascension Texas Cardiovascular, Ascension Seton, Austin, Texas, USA.
- Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Cardiology and Cardiothoracic Surgery, Children's Health of Ireland at Crumlin, Dublin, Ireland.
- The Davis Women's Heart Center at the DeBakey Heart & Vascular Institute, Houston Methodist Medical Center, Houston, Texas, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA.
- Center for Inherited Cardiovascular Disease, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Zitieren
APA
Abdelfattah, O. M., Abdeldayem, J., Hassan, A. A., Gulati, M., Phillips, S., Owens, A. T., Sharma, G., Wood, M. J., Pirwitz, M. J., Shepherd, M. C., Sibai, B., Link, M. S., Nagueh, S. F., & Martinez, M. W. (2026). Clinical Considerations in Management of Hypertrophic Cardiomyopathy in Pregnancy. JACC. https://doi.org/10.1016/j.jacc.2026.06.004
Vancouver
Abdelfattah OM, Abdeldayem J, Hassan AA, Gulati M, Phillips S, Owens AT, et al. Clinical Considerations in Management of Hypertrophic Cardiomyopathy in Pregnancy. JACC. 2026. doi:10.1016/j.jacc.2026.06.004
BibTeX
@article{Abdelfattah2026,
author = {Abdelfattah, Omar M and Abdeldayem, Jasmin and Hassan, Ahmed A and Gulati, Martha and Phillips, Sabrina and Owens, Anjali T and Sharma, Garima and Wood, Malissa J and Pirwitz, Mark J and Shepherd, Meghan C and Sibai, Baha and Link, Mark S and Nagueh, Sherif F and Martinez, Matthew W},
title = {Clinical Considerations in Management of Hypertrophic Cardiomyopathy in Pregnancy},
journal = {JACC},
year = {2026},
doi = {10.1016/j.jacc.2026.06.004}
}
EUVIMED